Yildirim, M. E. Et Al. 2025. Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC. Journal of Oncology Pharmacy Practice , vol.31, no.3 , 404-411.

Yildirim, M. E., Karadurmuş, N., Ökten, İ. N., TÜRK, H. M., Urakçı, Z., Arslan, Ç., ... Çelik, S.(2025). Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC. Journal of Oncology Pharmacy Practice , vol.31, no.3, 404-411.

Yildirim, Mahmut Et Al. "Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC," Journal of Oncology Pharmacy Practice , vol.31, no.3, 404-411, 2025

Yildirim, Mahmut E. Et Al. "Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC." Journal of Oncology Pharmacy Practice , vol.31, no.3, pp.404-411, 2025

Yildirim, M. E. Et Al. (2025) . "Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC." Journal of Oncology Pharmacy Practice , vol.31, no.3, pp.404-411.

@article{article, author={Mahmut Emre Yildirim Et Al. }, title={Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC}, journal={Journal of Oncology Pharmacy Practice}, year=2025, pages={404-411} }